Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Business

Novo Nordisk and Hims & Hers Turn Patent Dispute Into Business Opportunity

An employee walks past a door bearing the logo of Novo Nordisk at the factory in Hilleroed on September 26, 2023. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark, aiming to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. On June 12, 2023, the company announced plans to invest 15.9 billion Danish kroner to expand an existing Active Pharmaceutical Ingredient (API) production facility in the country.

A legal fight between Novo Nordisk and Hims & Hers Health has quickly turned into a business partnership.

The drugmaker has agreed to dismiss its patent lawsuit after the two companies struck a deal to sell popular weight-loss medicines through the telehealth platform.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.